Bellevue Group Ag Repligen Corp Transaction History

Bellevue Group Ag

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $1.06 Million - $1.69 Million	6,600 New	6,600 $1.24 Million
Q2 2020 Aug 13, 2020	SELL	$94.33 - $140.48 $1.28 Million - $1.91 Million	-13,600 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$73.84 - $93.08 $1 Million - $1.27 Million	13,600 New	13,600 $1.26 Million

479

54.9M

297K

343K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.15B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.